Dow Jones
39.308,57 -67,30 (-0,17%) Nasdaq
18.380,30 +27,54 (+0,15%) Nikkei 225
40.780,70 -131,67 (-0,32%) EUR/USD
1,0827 -0,0016 (-0,15%) Bitcoin EUR
51.989,98 -765,05 (-1,45%) CMC Crypto 200
1.208,27 +42,16 (+3,61%)
Integra LifeSciences Holdings Corporation (IART)
| Chiusura precedente | 28,84 |
| Aperto | 28,93 |
| Denaro | 28,59 x 200 |
| Domanda | 28,79 x 100 |
| Min-Max giorno | 28,55 - 29,21 |
| Intervallo di 52 settimane | 22,36 - 46,75 |
| Volume | |
| Media Volume | 1.603.119 |
| Capitalizzazione | 2,259B |
| Beta (mensile su 5 anni) | 1,11 |
| Rapporto PE (ttm) | 56,22 |
| EPS (ttm) | 0,51 |
| Prossima data utili | 24 lug 2024 - 29 lug 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 33,25 |
GlobeNewswireIntegra LifeSciences to Host Third Quarter 2023 Financial Results Conference Call on October 25, 2023
PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2023 financial results on Wednesday, October 25, 2023, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those pla
- GlobeNewswire
Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations. About Integra LifeSci
- GlobeNewswire
Integra LifeSciences Reports Second Quarter 2023 Financial Results
PRINCETON, N.J., July 26, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2023. Second Quarter 2023 Highlights Second quarter revenues of $381.3 million declined 4.2% on a reported basis and declined 2.7% on an organic basis compared to the prior year. Second quarter GAAP earnings per diluted share of $0.05, compared to $0.54 in the prior year; a
